|
Ascribe PLC - Comparative Business Analysis Snapshot
Business Description
Ascribe PLC. The Group's principal activity is developing, supplying and supporting software solutions. The Group's operation focuses on providing software solutions supporting patient, clinical and business processes to the international healthcare market. The Group's operation relates to hospital and pharmacy systems, emergency department, retail pharmacy, mental health, primary and social care. The Group's software products ensures that the drug prescribed will not react with any patient allergies, with any medicine the patient is already taking, and furthermore checks that the drug dose is correct for the patient's height, weight and other related information. Product brands include Ascribe, E-MAT, ePEX, Exeter, Park ETP and Symphony. The Group operates predominantly in the United Kingdom.
Competitor Analysis
This analysis compares Ascribe PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
